​

Funding Round

Series B - Immunitas Therapeutics

Series B - Immunitas Therapeutics

Investment Firm

Overview

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Announced Date

Aug 18, 2021

Closed on Date

Aug 18, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

14

Investor Name
Participant InvestorMirae Asset
Participant InvestorLongwood Fund
Participant InvestorEvotec
Participant InvestorLeukemia & Lymphoma Society
Participant InvestorNovartis Venture Fund

Round Details and Background

Immunitas Therapeutics raised $58000000 on 2021-08-18 in Series B

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 21, 2019
Series A - Immunitas Therapeutics
5-39.0M
Aug 18, 2021
Series B - Immunitas Therapeutics
16-58.0M

Recent Activity

There is no recent news or activity for this profile.